Gainers

• Agape ATP (NASDAQ:ATPC) stock moved upwards by 83.7% to $3.84 during Thursday's regular session. The market value of their outstanding shares is at $2.0 million. The company's, Q1 earnings came out 4 days ago.
• Akanda (NASDAQ:AKAN) stock moved upwards by 75.69% to $25.49. The company's market cap stands at $7.7 million.
• Co-Diagnostics (NASDAQ:CODX) shares moved upwards by 65.89% to $3.96. The company's market cap stands at $8.6 million.
• NewGenIvf Group (NASDAQ:NIVF) shares increased by 54.24% to $1.14.
• Liminatus Pharma (NASDAQ:LIMN) stock increased by 48.53% to $0.28. The company's market cap stands at $8.4 million.
• Sunshine Biopharma (NASDAQ:SBFM) shares moved upwards by 38.0% to $0.51. The company's market cap stands at $1.8 million.

Losers

• WORK Medical Tech Gr (NASDAQ:WOK) stock declined by 23.4% to $0.14 during Thursday's regular session.
• Wellgistics Health (NASDAQ:WGRX) stock fell 22.18% to $0.1. The market value of their outstanding shares is at $16.3 million. As per the news, the Q1 earnings report came out 2 days ago.
• QTREX Quantum Ltd. - Ordinary Shares (NASDAQ:QTEX) shares decreased by 21.9% to $0.31.
• Indaptus Therapeutics (NASDAQ:INDP) stock decreased by 21.14% to $0.97. The market value of their outstanding shares is at $2.7 million. As per the press release, Q1 earnings came out 4 days ago.
• SELLAS Life Sciences Gr (NASDAQ:SLS) shares declined by 19.84% to $7.19. The market value of their outstanding shares is at $1.6 billion.
• PRF Technologies (NASDAQ:PRFX) stock declined by 18.01% to $1.32. The market value of their outstanding shares is at $1.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.